Jim Baker | Vice President, Corporate Affairs |
Jeff Albers | Chief Executive Officer |
Kate Haviland | Chief Operating Officer |
Andy Boral | Chief Medical Officer |
Mike Landsittel | Chief Finance Officer |
Jason Jakoby | Goldman Sachs |
Marc Frahm | Cowen and Company |
Arlinda Lee | Canaccord |
Charles Zhu | Guggenheim Partners |
Good day, ladies and gentlemen, and welcome to the Q4 2018 Blueprint Medicines Corporation Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions] As a reminder, this conference call maybe recorded. I would now like to introduce your host for today's conference, Mr.